Ponatinib with fludarabine, cytarabine, idarubicin, and granulocyte colony-stimulating factor chemotherapy for patients with blast-phase chronic myeloid leukaemia (MATCHPOINT): a single-arm, multicentre, phase 1/2 trial

Mhairi Copland, Daniel Slade, Graham McIlroy, Gillian A. Horne, Jenny Byrne, Kate Rothwell, Kristian Brock, Hugues de Lavallade, Charles Craddock, Richard E Clark, Matthew L Smith, Rachel Fletcher, Rebecca Bishop, Dragana Milojković, Christina Yap